Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.280
-0.100 (-4.20%)
Mar 3, 2026, 2:29 PM EST - Market open
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $11.25 million as of March 3, 2026. Its market cap has increased by 195.99% in one year.
Market Cap
11.25M
Enterprise Value
5.43M
1-Year Change
195.99%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $11.25M, a decrease of -84.09%. That is a compound annual growth rate of -17.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 4.80M | -28.36% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 12.68M |
| Cellectar Biosciences | 12.68M |
| GT Biopharma | 12.45M |
| CytoMed Therapeutics | 12.23M |
| Chemomab Therapeutics | 12.06M |
| Soligenix | 11.80M |
| Longeveron | 11.63M |
| Imunon | 11.19M |